Healthcare

News from Tokyo Headquarters

See All

• Apr 4, 2022

  Fujifilm Completes Acquisition of a Dedicated Cell Therapy Manufacturing Facility from Atara Biotherapeutics, Inc.

• Mar 22, 2022

  Transfer of FUJIFILM Toyama Chemical's Radiopharmaceutical Business
  Amendment in relation to a return of domestic marketing rights for a product

• Sep 2, 2021

  Transfer of FUJIFILM Toyama Chemical's Radiopharmaceutical Business to PeptiDream

• Aug 31, 2021

  Launch of Therapeutic Radiopharmaceutical Product, Lutathera^® Injection targeting neuroendocrine tumors in Japan  (FUJIFILM Toyama Chemical)

• Jun 29, 2021

  $850 Million USD (¥90 Billion Yen) investment in FUJIFILM Diosynth Biotechnologies to add additional development and manufacturing capacity